Recent derivatives from smaller classes of fermentation-derived antibacterials.

Area of Science:

• Microbiology
• Medicinal Chemistry
• Drug Discovery

Background:

• Urgent need for novel antibiotics to combat antimicrobial resistance.
• Exploration of underutilized fermentation-derived antibiotic classes.
• Development of new derivatives and analogs through medicinal chemistry and biosynthetic pathway manipulation.

Purpose of the Study:

• To review recent advancements in discovering new antibacterial derivatives.
• To highlight the potential of underinvestigated natural product antibiotic classes.

Main Methods:

• Literature review of patents and journals from 2007 to present.
• Focus on new antibacterial derivatives from fermentation-derived sources.

Main Results:

• Several programs have yielded clinical candidates in preclinical or early clinical trials.
• Renewed investigations demonstrate potential for discovering new clinical candidates.

Conclusions:

• Underdeveloped fermentation-derived antibiotic classes offer significant potential for new drug discovery.
• Exploring underinvestigated natural products is a viable strategy to combat resistant pathogens.
• New antibiotics are crucial additions to the physician's armamentarium.